ACRBP and cancer: NuMA overexpression was suggested to cause mitotic perturbations required for the plasticity of the preneoplastic genome, with co-evolving overexpression of ACRBP as tumours progress driving the acquisition of traits for the normalization of these early perturbations that could otherwise be disadvantageous for cancer cell proliferation by promoting mitotic catastrophe.